Immune cell therapy takes on hard-to-treat lymphoma in major trial
NCT ID NCT05371093
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a personalized cell therapy (axicabtagene ciloleucel) works better than standard treatments for people with follicular lymphoma that has come back or stopped responding. About 231 adults with this slow-growing blood cancer will receive either the cell therapy or usual care. The main goal is to see how long the cancer stays away.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST Papa Giovanni XXIII
Bergamo, 24128, Italy
-
Arcispedale Santa Maria Nuova
Reggio Emilia, 42123, Italy
-
Azienda Ospedallero-Universitaria di Bologna Policlinico Sant'Orsola-Malpighi
Bologna, 40138, Italy
-
CHU Bordeaux - Hospital Haut-Leveque - Centre Francois Magendie
Pessac, 33604, France
-
CHU de Dijon
Dijon, 21079, France
-
CHU de Poitiers
Poitiers, 86021, France
-
Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 2QQ, United Kingdom
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Duarte, California, 91010, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Fondazione IRCCS - Istituto Nazionale Tumori
Milan, 20100, Italy
-
Henry-Joyce Cancer Clinic
Nashville, Tennessee, 37232, United States
-
Hopital Henri Mondor
Créteil, 94010, France
-
Hopital Pitie-Salpetriere
Paris, 75013, France
-
Hopital Pontchaillou - CHU Rennes
Rennes, 35033, France
-
Hopital Saint Eloi
Montpellier, 34295, France
-
Hospital 12 de Octubre
Madrid, 28041, Spain
-
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
-
Hospital Clínico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital General Universitario Gregorio Maranon
Madrid, 28009, Spain
-
Hospital Universitari Vall d'Hebrón
Barcelona, 08035, Spain
-
Hospital Universitario Virgen del Rocio
Seville, 41013, Spain
-
Hospital Universitario de Salamanca
Salamanca, 37007, Spain
-
Hyogo Medical University Hospital
Hyōgo, 663-8501, Japan
-
Hôpital Claude Huriez-CHU de Lille
Lille, 59037, France
-
Institut Paoli-Calmettes
Marseille, 13273, France
-
Instituto Catalan de Oncologia - Hospital Duran i Reynolds (ICO L'Hospitalet)
Barcelona, 08908, Spain
-
Istituto Clinico Humanitas-IRCCS
Rozzano, 20089, Italy
-
King's College Hospital NHS Foundation Trust
London, SE5 9RS, United Kingdom
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Novant Health Cancer Institute Hematology - Charlotte
Charlotte, North Carolina, 28204, United States
-
Okayama University Hospital
Okayama, 700-8558, Japan
-
Osaka University Hospital
Osaka, 565-0871, Japan
-
Ospedale San Raffaele
Milan, 20132, Italy
-
Oxford University Hospitals NHS Foundation Trust
Oxford, OX3 7LE, United Kingdom
-
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Stanford Health Care
Stanford, California, 94305, United States
-
The Christie NHS Foundation Trust
Manchester, M20 4BX, United Kingdom
-
The Royal Marsden NHS Foundation Trust
Sutton, SM2 5PT, United Kingdom
-
The University Hospital Southampton NHS Foundation Trust
Southampton, SO16 6YD, United Kingdom
-
The University of Kansas Hospital
Westwood, Kansas, 66205, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Tohoku University Hospital
Miyagi, 980-8574, Japan
-
TriStar Centennial Medical Center - Cell Processing
Nashville, Tennessee, 37203, United States
-
Universitatsklinikum Koln Klinik I fur Innere Medizin
Würzburg, 97080, Germany
-
Universitatsmedizin Gottingen
Göttingen, 37075, Germany
-
University College London Hospitals NHS Foundation Trust
London, NW2 2QG, United Kingdom
-
University Hospital Birmingham NHS Foundation Trust
Birmingham, B15 2GW, United Kingdom
-
University Hospital Kyoto Prefectural University of Medicine
Kyoto, 602-8566,, Japan
-
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, 21201, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New cocktail of four drugs hopes to tackle tough lymphoma
- New hope for lymphoma patients: experimental drug combo enters final trial phase
- New hope for lymphoma patients: mosunetuzumab under review
- New immune cell combo tackles tough lymphoma
- Off-the-Shelf CAR t cells take on tough lymphomas
- New hope for lymphoma patients: zanubrutinib combo enters phase 3 trial